Takeda Uses Fine Tooth Comb To Find Inefficiencies After Poor Results
The belt-tightening has already hit Takeda’s oncology arm, leading to the exit of Deborah Dunsire, chief executive officer at Millennium: The Takeda Oncology Co.
The belt-tightening has already hit Takeda’s oncology arm, leading to the exit of Deborah Dunsire, chief executive officer at Millennium: The Takeda Oncology Co.